摘要
目的:建立拉氧头孢钠药物利用评价标准,为儿科临床合理应用拉氧头孢钠提供参考依据。方法:参考拉氧头孢钠的药品说明书及应用指南等,在查阅相关文献的基础上制定儿科药物利用评价细则,并通过加权TOPSIS法对南京医科大学附属儿童医院2019年上半年120例应用拉氧头孢钠的出院病历进行评价。结果:120份病历中,相对接近度大于90%有16例(13.3%),介于80%~90%间有28例(23.3%),相对接近度介于70%~80%间的有32例(占26.7%),相对接近度介于60%~70%间的有27例(22.5%),相对接近度小于60%的有17例(14.2%)。结论:加权TOPSIS法可以用于拉氧头孢钠在儿科中的药物应用合理性评价,该院拉氧头孢钠的不合理应用情况仍存在,应加强临床规范合理用药。
OBJECTIVE To establish weighted TOPSIS method for evaluating Latamoxef Sodium and provide references for rational dosing of Latamoxef Sodium in pediatrics. METHODS The rational dosing evaluation system of Latamoxef Sodium was established with reference to its package insert and the relevant guidelines.After a literature review,120 archived medical records of Latamoxef Sodium in the first half of 2019 at a hospital were evaluated according to these rules.RESULTS Among 120 cases,there were 16 cases in relative proximity>90%(13.3%),28 cases in relative proximity between 80%to 90%(23.3%),32 cases in relative proximity between 70%to 80%(26.7%),27 cases in relative proximity between 60%to 70%(22.5%)and 17 cases in relative proximity<60%(14.2%).CONCLUSION To adopt Weighted TOPSIS is both reasonable and feasible as a drug utilization method of Latamoxef Sodium in pediatrics.Apparently irrational use of Latamoxef Sodium still persists in clinical practices.Thus it is imperative to render drug dosing more standardized and rational.
作者
王绚
张永
WANG Xuan;ZHANG Yong(Affiliated Children's Hospital,Nanjing Medical University,Jiangsu Nanjing 210008,China)
出处
《中国医院药学杂志》
CAS
北大核心
2021年第2期210-214,共5页
Chinese Journal of Hospital Pharmacy
基金
十三五南京市卫生青年人才培养工程第三层次(编号:QRX17173)
南京药学会-常州四药医院药学科研基金(编号:2019YX026)。
